Skip to content

Genelux Corporation

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Genelux grants ELIAS Animal Health worldwide exclusive license for V-VET1

    Genelux announced an exclusive worldwide licensing agreement with ELIAS Animal Health for V-VET1, granting ELIAS rights to develop and commercialize the veterinary cancer treatment candidate.